Literature DB >> 19596743

Cis-ruption mechanisms: disruption of cis-regulatory control as a cause of human genetic disease.

Dirk-Jan Kleinjan1, Pedro Coutinho.   

Abstract

The spatiotemporally and quantitatively correct activity of a gene requires the presence of intact coding sequence as well as properly functioning regulatory control. One of the great challenges of the post-genome era is to gain a better understanding of the mechanisms of gene control. Proper gene regulation depends not only on the required transcription factors and associated complexes being present (in the correct dosage), but also on the integrity, chromatin conformation and nuclear positioning of the gene's chromosomal segment. Thus, when either the cis-trans regulatory system of a gene or the normal context of its chromatin structure are disrupted, gene expression may be adversely affected, potentially leading to disease. As transcriptional regulation is a highly complex process depending on many factors, there are many different mechanisms that can cause aberrant gene expression. Traditionally, the term 'position effect' was used to refer to situations where the level of expression of a gene is deleteriously affected by an alteration in its chromosomal environment, while maintaining an intact transcription unit. Over the past years, an ever increasing number of such disease-related position effect cases have come to light, and detailed studies have revealed insight into the variety of causes, which can be categorized into a number of different mechanistic groups. We suggest replacing the outdated term of 'position effect disease' with the new generic name of 'cis-ruption disorder' to describe genetic disease cases that are caused by disruption of the normal cis-regulatory architecture of the disease gene locus. Here, we review these various cis-ruption mechanisms and discuss how their studies have contributed to our understanding of long- range gene regulation.

Entities:  

Mesh:

Year:  2009        PMID: 19596743     DOI: 10.1093/bfgp/elp022

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  39 in total

Review 1.  Topology of mammalian developmental enhancers and their regulatory landscapes.

Authors:  Wouter de Laat; Denis Duboule
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

2.  A distant downstream enhancer directs essential expression of Tbx18 in urogenital tissues.

Authors:  C Chase Bolt; Colleen M Elso; Xiaochen Lu; Fuming Pan; Andreas Kispert; Lisa Stubbs
Journal:  Dev Biol       Date:  2014-05-20       Impact factor: 3.582

Review 3.  Regulation of disease-associated gene expression in the 3D genome.

Authors:  Peter Hugo Lodewijk Krijger; Wouter de Laat
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-09       Impact factor: 94.444

Review 4.  Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences.

Authors:  Shipra Bhatia; Dirk A Kleinjan
Journal:  Hum Genet       Date:  2014-02-05       Impact factor: 4.132

5.  Variegated gene expression caused by cell-specific long-range DNA interactions.

Authors:  Daan Noordermeer; Elzo de Wit; Petra Klous; Harmen van de Werken; Marieke Simonis; Melissa Lopez-Jones; Bert Eussen; Annelies de Klein; Robert H Singer; Wouter de Laat
Journal:  Nat Cell Biol       Date:  2011-06-26       Impact factor: 28.824

Review 6.  Enhancers as information integration hubs in development: lessons from genomics.

Authors:  Christa Buecker; Joanna Wysocka
Journal:  Trends Genet       Date:  2012-04-07       Impact factor: 11.639

7.  EnDisease: a manually curated database for enhancer-disease associations.

Authors:  Wanwen Zeng; Xu Min; Rui Jiang
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

8.  Small noncoding differentially methylated copy-number variants, including lncRNA genes, cause a lethal lung developmental disorder.

Authors:  Przemyslaw Szafranski; Avinash V Dharmadhikari; Erwin Brosens; Priyatansh Gurha; Katarzyna E Kolodziejska; Ou Zhishuo; Piotr Dittwald; Tadeusz Majewski; K Naga Mohan; Bo Chen; Richard E Person; Dick Tibboel; Annelies de Klein; Jason Pinner; Maya Chopra; Girvan Malcolm; Gregory Peters; Susan Arbuckle; Sixto F Guiang; Virginia A Hustead; Jose Jessurun; Russel Hirsch; David P Witte; Isabelle Maystadt; Neil Sebire; Richard Fisher; Claire Langston; Partha Sen; Paweł Stankiewicz
Journal:  Genome Res       Date:  2012-10-03       Impact factor: 9.043

9.  Characterization of GJB2 cis-regulatory elements in the DFNB1 locus.

Authors:  Stéphanie Moisan; Anaïs Le Nabec; Alicia Quillévéré; Cédric Le Maréchal; Claude Férec
Journal:  Hum Genet       Date:  2019-10-04       Impact factor: 4.132

10.  Platelet defects in congenital variant of Rett syndrome patients with FOXG1 mutations or reduced expression due to a position effect at 14q12.

Authors:  Christophe Goubau; Koen Devriendt; Nathalie Van der Aa; An Crepel; Dagmar Wieczorek; Tjitske Kleefstra; Marjolein H Willemsen; Anita Rauch; Andreas Tzschach; Thomy de Ravel; Peter Leemans; Chris Van Geet; Gunnar Buyse; Kathleen Freson
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.